Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R4QF
|
||||
Former ID |
DNC005338
|
||||
Drug Name |
HERKINORIN
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529401] | ||
Structure |
Download2D MOL |
||||
Formula |
C28H30O8
|
||||
Canonical SMILES |
CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OC(=O)C4=CC=CC=<br />C4)C)C5=COC=C5
|
||||
InChI |
1S/C28H30O8/c1-27-11-9-18-26(32)36-21(17-10-12-34-15-17)14-28(18,2)23(27)22(29)20(13-19(27)25(31)33-3)35-24(30)16-7-5-4-6-8-16/h4-8,10,12,15,18-21,23H,9,11,13-14H2,1-3H3/t18-,19-,20-,21-,23-,27-,28-/m0/s1
|
||||
InChIKey |
PYDQMXRFUVDCHC-XAGHGKQISA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [529401] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [529401] | ||
Delta-type opioid receptor | Target Info | Inhibitor | [529401] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.